Membrane Reactor Modules for French Wastewater Plant

Water/Wastewater

Membrane Reactor Modules for French Wastewater Plant

11 Jan, 2011

Published over 15 years ago. See the latest and most current information on Water/Wastewater.

The Koch Membrane Systems (USA) has been selected by OTV France SNC (Veolia Group) to provide PURON® membrane bioreactor modules for the wastewater treatment plant at “Carré de Reunion” in the Versailles region, France. The project will upgrade and expand the capacity of the existing conventional wastewater treatment plant.

The plant is located adjacent to the gardens of the Palace of Versailles and is owned by “Le Syndicat Mixte d’Assainissement de la Région Ouest de Versailles” (SMAROV). The treated wastewater will be discharged into the small “Ru de Gally” stream, a side arm of the river Seine which has its source in the palace gardens.

The plant is designed for an annual average flow of 43,500 m3/d, with peaks up to 6.000 m³/hour. The upgrade of the existing conventional wastewater treatment plant with MBR technology will allow to achieve effluent quality requirements to meet future legal requirements of the European Community.

The delivery of the PURON membrane modules is scheduled for end of 2012/early 2013; the start-up will be in 2013. The treatment plant will be Koch Membrane Systems’ largest MBR project in Europe. The demand for PURON MBR technology in France continuous to increase steadily with thirteen orders and start-ups in the last twelve months for large-scale municipal projects, some of them with a capacity of more than 20,000 m3/d.

Latest News

Explore Our Other Sites

Labmate Online
Scientists solve 80-year-old riddle of why virus-infected cells behave so differently
Explore more Arrow
Envirotech Online
New civil penalties and real-time monitoring raise the bar for water company compliance
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow